Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells

Blood

Volumn 116, Issue 20, 2010, Pages 4202-4211

  Stanelle, Jens ^a   Döring, Claudia ^b   Hansmann, Martin Leo ^b   Küppers, Ralf ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 5; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; STAT4 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; CELL SURVIVAL; CLASSICAL HODGKIN LYMPHOMA; CYTOKINE RELEASE; DOWN REGULATION; GENE CONTROL; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REED STERNBERG CELL; SIGNAL TRANSDUCTION;

EID: 78349241478     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-265827     Document Type: Article

References (37)

1. Schmitz R, Stanelle J, Hansmann ML, et al. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol. 2009;4:151-174.
2. Schwering I, Bräuninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003;101(4):1505-1512. (Pubitemid 36182527)
3. Kanzler H, Küppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184(4):1495- 1505. (Pubitemid 26354704)
4. Bräuninger A, Hansmann ML, Strickler JG, et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and Non-Hodgkin's lymphoma. N Engl J Med. 1999;340(16):1239-1247.
5. Oudejans JJ, Kummer JA, Jiwa M, et al. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol. 1996;148(1):233-240.
6. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltration Hodgkin's lymphoma. Am J Pathol. 1999;154(6):1685-1691. (Pubitemid 29262850)
7. Scheeren FA, Diehl SA, Smit LA, et al. IL-21 is expressed in Hodgkin lymphoma and activates STAT5; evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood. 2008;111(9):4706-4715.
8. Küppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111(4):529-537. (Pubitemid 36228010)
9. Ting CN, Olson MC, Barton KP, et al. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 1996;384(6608):474-478.
10. Ouyang W, Ranganath SH, Weindel K, et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998;9(5):745-755.
11. Kishikawa H, Sun J, Choi A, et al. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol. 2001;167(8):4414-4420.
12. Schwenger GT, Fournier R, Kok CC, et al. GATA-3 has dual regulatory functions in human interleukin-5 transcription. J Biol Chem. 2001;276(51):48502-48509. (Pubitemid 37370764)
13. Albergaria A, Paredes J, Sousa B, et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptornegative tumours. Breast Cancer Res. 2009;11(3):R40.
14. Gulbinas A, Berberat PO, Dambrauskas Z, et al. Aberrant gata-3 expression in human pancreatic cancer. J Histochem Cytochem. 2006;54(2):161-169.
15. Amsen D, Antov A, Jankovic D, et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27(1):89-99.
16. Fang TC, Yashiro-Ohtani Y, Del Bianco C, et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity. 2007;27(1):100-110. (Pubitemid 47096803)
17. Jundt F, Acikgoz O, Kwon SH, et al. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia. 2008;22(8):1587-1594.
18. Jundt F, Anagnostopoulos I, Förster R, et al. Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002;99(9):3398-3403.
19. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 1997;100(12):2961-2969.
20. Hinz M, Lemke P, Anagnostopoulos I, et al. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med. 2002;196(5):605-617. (Pubitemid 35024439)
21. Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med. 2009;206(5):981-989.
22. Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712-716.
23. Das J, Chen CH, Yang L, et al. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol. 2001;2(1):45-50.
24. Stanelle J, Tu-Rapp H, Putzer BM. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53. Cell Death Differ. 2005;12(4):347-357.
25. Atayar C, Poppema S, Blokzijl T, et al. Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol. 2005;166(1):127-134. (Pubitemid 40051666)
26. Siegel MD, Zhang DH, Ray P, et al. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem. 1995;270(41):24548-24555.
27. Smirnov DV, Smirnova MG, Korobko VG, et al. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene. 1995;155(2):277-281.
28. Usui T, Nishikomori R, Kitani A, et al. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity. 2003;18(3):415-428.
29. van Hamburg JP, de Bruijn MJ, Ribeiro de Almeida C, et al. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur J Immunol. 2008;38(9):2573-2586.
30. Kapp U, Yeh WC, Patterson B, et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med. 1999;189(12):1939-1946.
31. Horie R, Watanabe T, Morishita Y, et al. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene. 2002;21(16):2493-2503. (Pubitemid 34438102)
32. Ohshima K, Akaiwa M, Umeshita R, et al. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology. 2001;38(4):368-375. (Pubitemid 34225031)
33. Skinnider BF, Elia AJ, Gascoyne RD, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97(1):250-255.
34. Oshima Y, Puri RK. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Cell Immunol. 2001;211(1):37-42.
35. Martone R, Euskirchen G, Bertone P, et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A. 2003;100(21):12247-12252.
36. Palomero T, Lim WK, Odom DT, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103(48):18261-18266. (Pubitemid 44871646)
37. Jundt F, Anagnostopoulos I, Förster R, et al. Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002;99(3):3398-3403.